Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;11(8):548-52.
doi: 10.1631/jzus.B1001004.

Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation

Xin Du  1 , Jun-ping Kang, Jia-hui Wu, Qiang Lv, Chao-shu Tang, Chang-sheng Ma
Affiliations

Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation

Xin Du et al. J Zhejiang Univ Sci B. 2010 Aug.

Abstract

Objective: Percutaneous coronary intervention (PCI) triggers an acute inflammatory response, while sirolimus is known to have anti-inflammatory properties; the inflammatory system response to PCI after sirolimus-eluting stent placement remains unclear. The purpose of this study is to determine the changes in high sensitive C-reactive protein (hs-CRP) and apelin after PCI procedure and drug-eluting stent implantation in patients with and without reduced left ventricular systolic function.

Methods: Forty-eight consecutive patients undergoing PCI at the Beijing Anzhen Hospital between July and September 2006 were recruited. Sirolimus-eluting stents were employed in all patients. Blood samples were drawn immediately before and 24 h after the procedure. Plasma hs-CRP and apelin levels were determined by enzyme immunoassay.

Results: Paired t-test revealed a significant increase in both hs-CRP and apelin post-procedure (P=0.006 and P<0.0001, respectively). Patients with reduced left ventricular ejection fraction (LVEF) had significantly lower baseline apelin levels compared to those with normal ventricular function [(46.8+/-10.8) vs. (72.0+/-8.4) pg/ml, P<0.001]. However, apelin increased to a level similar to the level of those with normal left ventricular systolic function 24 h after the PCI procedure [(86.7+/-11.6) vs. (85.1+/-6.1) pg/ml, P=0.72].

Conclusions: hs-CRP and apelin levels increased after PCI and sirolimus-eluting stent implantation. Patients with impaired left ventricular systolic function had significantly lower baseline apelin levels, which increased significantly after PCI.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mean plasma apelin levels in subjects with normal and reduced left ventricular ejection fraction (LVEF) pre- and post-procedure P<0.001 between pre- and post-procedure for each group; P<0.001 between baseline apelin levels; No significant difference (P=0.72) between the two groups after the procedure
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Almagor M, Keren A, Banai S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. American Heart Journal. 2003;145(2):248–253. doi: 10.1067/mhj.2003.16. - DOI - PubMed
    1. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. The American Journal of Medicine. 2006;119(12):1056–1061. doi: 10.1016/j.amjmed.2006.01.023. - DOI - PubMed
    1. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation. 2003;108(12):1432–1439. doi: 10.1161/01.CIR.0000091235.94914.75. - DOI - PubMed
    1. Ellinor PT, Low AF, MacRae CA. Reduced apelin levels in lone atrial fibrillation. European Heart Journal. 2006;27(2):222–226. doi: 10.1093/eurheartj/ehi648. - DOI - PubMed
    1. Gogo PB, Schneider DJ, Watkins MW, Terrien EF, Sobel BE, Dauerman HL. Systemic inflammation after drug-eluting stent placement. Journal of Thrombosis and Thrombolysis. 2005;19(2):87–92. doi: 10.1007/s11239-005-1378-6. - DOI - PubMed

Publication types